Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature-Reference-Cited by-同舟云学术

Are syngeneic donors a viable donor option in allogeneic haematopoietic cell transplantation for MDS? A brief report on behalf of the Chronic Malignancies Working Party of the EBMT and review of current literature

Published:2023-04-25 Issue:8 Volume:58 Page:942-945
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Robin Marie^ORCID,Gras Luuk,Koster Linda,Saccardi Riccardo^ORCID,Finke Jürgen^ORCID,Forcade Edouard^ORCID,Rovira Montserrat,Kobbe Guido,Reményi Péter,Apperley Jane^ORCID,Smaranda Arghirescu,Bay Jacques-Olivier,Casper Jochen,de Wreede Liesbeth C.^ORCID,Giebel Sebastian,Grillo Giovanni,Heras Inmaculada,Potter Victoria,Tischer Johanna^ORCID,Trociukas Ilze,Nachbaur David,Drozd-Sokolowska Joanna^ORCID,Raj Kavita^ORCID,Gurnari Carmelo^ORCID,Yakoub-Agha Ibrahim,Onida Francesco,Scheid Christof,McLornan Donal^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-01991-9.pdf

Reference20 articles.

1. Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997;89:2079–88.

2. Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Solé F, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120:2454–65.

3. Bernard E, Tuechler H, Greenberg PL, Hasserjian RP, Arango Ossa JE, Nannya Y, et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid. 2022;1:EVIDoa2200008.

4. Robin M, Porcher R, Ades L, Raffoux E, Michallet M, Francois S, et al. HLA-matched allogeneic stem cell transplantation improves outcome of higher risk myelodysplastic syndrome A prospective study on behalf of SFGM-TC and GFM. Leukemia. 2015;29:1496–501.

5. Kröger N, Sockel K, Wolschke C, Bethge W, Schlenk RF, Wolf D, et al. Comparison between 5-azacytidine treatment and allogeneic stem-cell transplantation in elderly patients with advanced MDS according to donor availability (VidazaAllo Study). J Clin Oncol. 2021;39:3318–27.